Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s Tecfidera Time-Out Pays Off

[at Motley Fool] – A decision to put off the launch of Biogen’s (BIIB) highly anticipated launch of its MS drug Tecfidera in Europe appears to have paid off, thanks to expanded patent . . . → Read More: Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s Tecfidera Time-Out Pays Off Similar posts: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Biogen wins protection for MS drug Tecfidera in Europe Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB) Boeing’s Double Top: Will the company continue to soar?